Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohortClémentine Carlet, Charlée Nardin, Julie De Quatrebarbes et al.|Journal of the American Academy of Dermatology|2021Cited by 9
Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE).Charlée Nardin, F. Aubin, Wendy Lefevre et al.|Journal of Clinical Oncology|2020Cited by 3